Clinical Trial Update: A Randomised Trial of Artesunate-sulfamethoxypyrazine/Pyrimethamine Versus Praziquantel for the Treatment of S. Mansoni [Phase 3]

View source ↗

Summary

Phase 3 randomized trial comparing artesunate-sulfamethoxypyrazine/pyrimethamine versus praziquantel for Schistosoma mansoni; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schistosomiasis Mansoni

Drugs mentioned

• Artesunate-sulfamethoxypyrazine/pyrimethamine (Artesunate-sulfamethoxypyrazine/pyrimethamine)
• Praziquantel (Praziquantel)

Snippet

Sponsor: Kenya Medical Research Institute | Conditions: Schistosoma Mansoni | Phase 3 | Status: COMPLETED